We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| HH&L Acquisition Co | NYSE:HHLA | NYSE | Equity Warrant |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 10.75 | 0 | 01:00:00 |
From Jul 2022 to Jul 2024
By Dean Seal
DiaCarta Ltd. said U.S. regulators have granted Emergency Use Authorization to its test kit for monkeypox infections.
The molecular diagnostics and disease-testing company said Thursday morning that the U.S. Food and Drug Administration extended the approval to its QuantiVirus MPXV test.
The test detects the monkeypox virus from lesion swabs and is designed for laboratory use.
DiaCarta agreed in October to be acquired and taken public by the blank-check company HH&L Acquisition Co. in a deal that gave DiaCarta an implied pre-money equity value of $460 million. The merger is expected to close this quarter.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 12, 2023 09:07 ET (14:07 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year HH&L Acquisition Chart |
1 Month HH&L Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
